Signal2026-06-29
ClinicalTrials.gov

[PHASE1] Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

Part of

Emerging Cancer Biomarker Techniques